Description: Q BioMed Inc. ''Q`` is a biomedical acceleration and development company focused on acquiring companies and biomedical assets in clinical stage or and near revenue development. Q is dedicated to providing these target companies strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.
Home Page: www.qbiomed.com
366 Madison Avenue
New York,
NY
10017
United States
Phone:
212 588 0022
Officers
| Name | Title |
|---|---|
| Mr. Denis D. Corin | Chairman, CEO & Pres |
| Mr. William S. Rosenstadt | Chief Legal Officer, Gen. Counsel & Director |
| Mr. David Laskow-Pooley | VP of Product Devel. |
| Mr. Robert Derham | VP of Orphan Products |
| Mr. Ari Jatwes | Bus. Devel. Analyst |
| Dr. Amy Ripka | Medicinal Chemistry Advisor |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 109.8901 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 330.4621 |
| Price-to-Sales TTM: | 2.5478 |
| IPO Date: | |
| Fiscal Year End: | November |
| Full Time Employees: | 3 |